The VA, Psychedelics, and the Future of Mental Health: A Conversation with Shereef Elnahal, Former VA Under Secretary for Health Post published:April 14, 2025 Post category:Interviews
Pα+ Psychedelic Bulletin #193: VA Secretary on Psychedelics; Preprint Challenges Replicability of Psilocybin’s Persistent Effects in Mice; Market Mayhem and Agency Shake-Ups Post published:April 11, 2025 Post category:Psychedelic Bulletin/Pα+
Psychedelic Policy Update: Medical Access, Industry Influence, and Voter Suppression Shape 2025 Landscape Post published:April 9, 2025 Post category:Analysis/News/Pα+
BREAKING: New Mexico Passes Nation’s First Legislature-Driven Psilocybin Access Act Post published:April 8, 2025 Post category:Analysis/News
March 2025’s Psychedelic Policy Momentum: New Bills Filed Across the U.S. as Nearly 30 States Deliberate Reforms Post published:April 7, 2025 Post category:Analysis/News/Pα+
Behind the Bill: Inside a Bipartisan Effort to Bring Psychedelic Therapy to Veterans Post published:April 4, 2025 Post category:Interviews
Transcend Posts Positive Phase 2 Data from Methylone for PTSD Program Post published:March 31, 2025 Post category:Analysis/News/Pα+
Pα+ Psychedelic Bulletin #192: Psychedelic Safety; Compass’ Lacklustre Long-Term Data; LSD Microdosing No Better than Placebo in ADHD Post published:March 28, 2025 Post category:Psychedelic Bulletin/Pα+
February 2025 Psychedelic Patent Update: Terran Secures New Overlapping IP; Porta Sophia Becomes USPTO Information Source Post published:March 27, 2025 Post category:Psychedelic Patent Analysis/Pα+
Beyond Guinea Pigs: Ensuring Access to Psychedelic Therapies for Europeans Post published:March 25, 2025 Post category:Analysis/News